| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |